Illinois CancerCare-Macomb
Macomb, Illinois, United States
Cancer treatment center in Macomb, Illinois
501 E Grant St, Macomb, IL 61455
About Illinois CancerCare-Macomb
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
155
Alliance for Clinical Trials in Oncology
77
SWOG Cancer Research Network
57
ECOG-ACRIN Cancer Research Group
26
NRG Oncology
8
GOG Foundation
5
Gynecologic Oncology Group
5
NSABP Foundation Inc
5
Wake Forest University Health Sciences
5
Children's Oncology Group
2
Eastern Cooperative Oncology Group
2
Clinical Trials at Illinois CancerCare-Macomb
During the past decade, Illinois CancerCare-Macomb conducted 178 clinical trials. In the 10-year time frame, 178 clinical trials started and 152 clinical trials were completed, i.e. on
average, 85.4% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 69 clinical trials were completed. i.e. 113.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
1984-06-01
Active, not recruiting
9,000
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
2004-09-01
2013-05-01
Completed
52
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
2006-03-01
2015-08-01
Completed
97
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2005-07-26
2022-05-20
Completed
70
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Illinois CancerCare-Macomb" #1 sponsor was "National Cancer Institute (NCI)" with 155 trials, followed by "Alliance for Clinical Trials in Oncology" with 77 trials
sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology"
with 26 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Macomb"
#1 collaborator was "National Cancer Institute (NCI)" with 193 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 42 different institutions and companies that were
collaborators in the rest 38 trials.
Clinical Trials Conditions at Illinois CancerCare-Macomb
According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Macomb" are
"Breast Cancer" (18 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Lymphoma" (10 trials) and "Recurrent Breast Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Macomb" in a lesser frequency.
Clinical Trials Intervention Types at Illinois CancerCare-Macomb
Most popular intervention types in "Illinois CancerCare-Macomb" are "Drug" (280 trials), "Other" (214 trials), "Biological" (138 trials), "Procedure" (83 trials) and "Radiation" (51 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (94 trials), "Quality-of-Life Assessment" (82 trials), "Questionnaire Administration" (56 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (40 trials). Other intervention names were less common.
Clinical Trials Genders at Illinois CancerCare-Macomb
The vast majority of trials in "Illinois CancerCare-Macomb" are
289 trials for "All" genders, 52 trials for "Female" genders and 9 trials for "Male" genders.
Clinical Trials Status at Illinois CancerCare-Macomb
Currently, there are NaN active trials in "Illinois CancerCare-Macomb".
undefined are not yet recruiting,
90 are recruiting,
140 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 92 completed trials in Illinois CancerCare-Macomb,
9 suspended trials,
and 16 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois CancerCare-Macomb, 20 "Phase 1"
clinical trials were conducted, 178 "Phase 2" clinical
trials and 165 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 8 trials that are defined as “Not Applicable".